TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06715956

Intervention type: OTHER
Intervention: Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis
Description: This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.

Intervention type: OTHER
Intervention: Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis
Description: This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.

Intervention type: OTHER
Intervention: Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis
Description: This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.

Intervention type: OTHER
Intervention: Observational Cohort Classification of Inflammatory Subtypes in Bronchiectasis
Description: This observational study classifies patients with non-cystic fibrosis bronchiectasis into inflammatory subtypes based on sputum analysis. No active treatment or intervention is administered during this observational phase. Participants will later be considered for treatment with HSK31858 as part of an independent clinical trial.
Study: NCT06717165

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: ERP combined with high-definition active tACS
Description: The active tACS +ERP referred to a period of tACS applied in the first 20 minutes of the ERP treatment (the tACS device was activated when ERP began and deactivated automatically while ERP continued). The total treatment phase lasted eight weeks and included ten sessions with experienced psychotherapists following a specific manual for the tACS+ERP treatment. Based on the EEG parameters, individualized modeling was conducted to determine specific stimulation parameter schemes (stimulation frequency). Anode electrode will be localized in front of the mPFC on the FpZ point according to the EEG international reference. Four cathode electrodes will be placed around (i.e. AF7, AF8, F3, F4).

Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: ERP combined with sham tACS
Description: Patients will get the same CBT setting as the active tACS group and they were applied the sham tACS cocurrently with ERP. The sham tACS device is the same as the active comparator's except that the sham tACS will only deliver a current stimulation for the first and last 15 seconds in order to produce somatic sensation in patients similar to that induced by the active tACS.
Study: NCT06715475

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Food containing plasmalogen
Description: Take five capsules per day in the morning.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Food not containing plasmalogen
Description: Take five capsules per day in the morning.
Study: NCT06718140

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound to one of the 4 brain locations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound to one of the 4 brain locations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound to one of the 4 brain locations

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound to one of the 4 brain locations
Study: NCT06714838

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab (Mabthera)
Description: Rituximab will be administered in a hospital setting in the course of one day. It will be given intravenously, at time points baseline, week 2 and week 26.
Study: NCT05743374

Intervention type: OTHER
Group type: OTHER
Intervention: Normal diet
Description: These patients will be given advice about a normal healthy diet.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: E400 elimination
Description: Patients in the intervention group will be given advice how to eliminate E440 additives with regard to carragenan, CMC and polysorbates.
Study: NCT06524089

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilate training
Description: Pilates based training exercises group will perform Pilates divided into two levels (beginner and intermediate). Each level will last for six sessions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric training
Description: eccentric trunk training exercises group:The course of the intervention period is 12 sessions total, exercises performed for two to three sets with 10 to 15 repetitions each set and 2 min rest between each set
Study: NCT05849597

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h.
Study: NCT04948112

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: real time continuous glucose monitor
Description: CGM sensor will read blood glucose every 10 minutes

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: blinded continuous glucose monitor
Description: CGM that records blood glucose but not visible to patient
Study: NCT06218823

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Transdermal Nicotine Patch
Description: a stop smoking aid, 21 milligrams(mg), 14mg, or 7mg of nicotine delivered over 24 hours

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Telephone Counseling
Description: 3 brief telephone-based smoking cessation counseling sessions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: 12 weeks of an oral smoking cessation medication

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cancer-Targeted Telephone Counseling
Description: 7 telephone-based smoking cessation counseling sessions adapted for cancer patients

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mailed Information about Standard Care Resources
Description: Publicly funded treatment resources including the SmokefreeTXT program sponsored by the National Cancer Institute and the Wisconsin Tobacco Quit Line.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mailed Information about Standard Care Resources
Description: Publicly funded treatment resources including the SmokefreeTXT program sponsored by the National Cancer Institute and the Wisconsin Tobacco Quit Line.
Study: NCT04622397

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Local subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision
Study: NCT06221553

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: B7H3 specific CAR T cell with IL-7Ra signaling domain
Description: Autologous T cells lentivirally transduced to express a B7H3 specific chimeric antigen receptor (CAR) with additional of IL-7 receptor alpha signalingdomain given via indwelling central nervous system (CNS) catheter
Study: NCT05757323

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: infant formula based on hydrolyzed protein
Description: infant formula based on hydrolysed protein

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: infant formula based on intact protein
Description: infant formula based on intact protein
Study: NCT05314894

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: Giving training to the students in the initiative group to quit smoking in three sessions, sending messages via whatsapp program and telephone counseling
Study: NCT05307887

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sync VR Medical PICO G2 4K Virtual Reality Technology
Description: Virtual reality headset and software
Study: NCT04665375

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DOR/3TC/TDF
Description: switch antiretroviral regimen to doravirine/lamivudine/tenofovir disoproxil fumarate once daily for 1 year
Study: NCT05434377

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ergocalciferol supplementation
Description: Participants in both groups will recieve ergocalciferol with different supplementation regimens for 6 months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ergocalciferol supplementation
Description: Participants in both groups will recieve ergocalciferol with different supplementation regimens for 6 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dialysis techniques
Description: Both groups will have participants treated with maintenance hemodialysis and peritoneal dialysis.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dialysis techniques
Description: Both groups will have participants treated with maintenance hemodialysis and peritoneal dialysis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sunlight exposure time
Description: Both groups will be advised to receive similar hours of daily sunlight exposure time.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sunlight exposure time
Description: Both groups will be advised to receive similar hours of daily sunlight exposure time.
Study: NCT06187623

Intervention type: OTHER
Intervention: Clinic based exercise
Description: 15 patients and their parents in the clinic-based group will be informed about the treatment program. Exercise training will be given to individuals by a physiotherapist trained in ISST- International Schroth 3-Dimensional Scoliosis Therapy.~Individuals in this group will be included in an exercise program 3 days a week (24 sessions) with a physiotherapist for 8 weeks. Each exercise session will last 50 minutes. Patients will be asked to do the given home exercises on the remaining 4 days of the week.

Intervention type: OTHER
Intervention: Home based exercise
Description: 15 patients in the home-based group and their parents will be informed about the treatment program. Exercise training will be given to individuals by a physiotherapist trained in ISST- International Schroth 3-Dimensional Scoliosis Therapy.~Individuals in this group will be included in an exercise program 1 day a week (8 sessions) accompanied by a physiotherapist for 8 weeks. Each exercise session will last 50 minutes. Patients will be asked to do the given home exercises on the remaining 6 days of the week.
Study: NCT04777578

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling based on fast-in fast-out technique in the teresa major muscle
Study: NCT05846295

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ESTIMATE
Description: An online educational module consisting of a video tutorial and feedback during a questionnaire

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ESTIMATE
Description: An online educational module consisting of a video tutorial and feedback during a questionnaire

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ESTIMATE
Description: An online educational module consisting of a video tutorial and feedback during a questionnaire
Study: NCT04786548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Patients will receive standardized pharmacotherapy with celecoxib 100mg twice daily for the first week, and will then, if well-tolerated, will be increased to 200mg twice daily for the next seven weeks.
Study: NCT06512025

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WWWT psychoeducative intervention
Description: What Were We Thinking (WWWT) is a highly structured, interactive, gender-informed, couples-based, psycho-educational program for parents and a first newborn to promote confident parental caretaking, optimize functioning in the intimate partner relationship and improve infant care manageability.~The adaptation of the WWWT programme (Catalan and Spanish version) comprises 2 sessions, each lasting 2 hours, that will be designed for groups of 5-7 families - within the first 6 weeks postpartum -, each consisting of mother, partner (or other caregiver) and their infant(s).
Study: NCT05865873

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health education
Description: Health education will be delivered for six months, two times per month; one session will take one hour, and an overall 12 sessions will be conducted. One health education session consists of key messages on normal pregnancy and childbirths, ODS during pregnancy, delivery, and the postpartum period, the practice of BPCR, and the benefits of MHSU. The other actions executed by WDT facilitators will be the motivating mother and their families to utilize MHS. One hour will be allocated for each session, from this 20 minutes will be allowed for the pre-recorded an audio-based lecturer and the remaining 40 minutes will be allowed for raising questions and responses (discussion). After the session, some of the women will be selected to carry out role play which is basic to demonstrate the important messages and share experiences.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health education
Description: Health education will be delivered for six months, two times per month; one session will take one hour, and an overall 12 sessions will be conducted. One health education session consists of key messages on normal pregnancy and childbirths, ODS during pregnancy, delivery, and the postpartum period, the practice of BPCR, and the benefits of MHSU. The other actions executed by WDT facilitators will be the motivating mother and their families to utilize MHS. One hour will be allocated for each session, from this 20 minutes will be allowed for the pre-recorded an audio-based lecturer and the remaining 40 minutes will be allowed for raising questions and responses (discussion). After the session, some of the women will be selected to carry out role play which is basic to demonstrate the important messages and share experiences.
Study: NCT04963595

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: 400 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: 400 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Initial dose 70 mg/m2 on days 1 and 8 (capsules) If well tolerated, subsequently 90 mg/m2 on days 1 and 8. Capsules on day 1 to be taken at the hospital, and on day 8 at home.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Initial dose 70 mg/m2 on days 1 and 8 (capsules) If well tolerated, subsequently 90 mg/m2 on days 1 and 8. Capsules on day 1 to be taken at the hospital, and on day 8 at home.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inetetamab
Description: 8mg/kg iv day 1 followed by 6mg/kg iv day 1, cycled every 21 days
Study: NCT05365009

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidisciplinary aproach
Description: regular tests
Study: NCT05028673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Capsule
Description: Hard capsule
Study: NCT06131658

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional motor control excercise
Description: This include functional motor control thrice a week for six weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: convectional excercise
Description: This include convectional exercise thrice a week for six weeks
Study: NCT06141824

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lucira COVID-19 & Flu Test
Description: The Lucira COVID-19 \& Flu Test is a rapid, single-use, molecular test for the qualitative detection and discrimination of SARS-CoV-2, Influenza A, and Influenza B viral RNA in nasal swab samples.
Study: NCT06406660

Intervention type: OTHER
Group type: OTHER
Intervention: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test
Description: This study conducts drug sensitivity tests on various clinically approved drugs. The most sensitive drug for the patient is selected for treatment. This study aims to evaluate the clinical effectiveness of treatment plans guided by organoid drug sensitivity tests.
Study: NCT05495438

Intervention type: OTHER
Intervention: Hypothetical AI
Description: n/a - There is no intervention. Clinicians will review the suggestions of a hypothetical AI
Study: NCT05028673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Tablet
Description: Film-coated tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Tablet
Description: Film-coated tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466 Tablet
Description: Film-coated tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antacid
Description: Oral suspension
Study: NCT05511428

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab and Hyaluronidase-fihj
Description: Given SC

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies
Study: NCT04672018

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Houtou Jianweiling tablet
Description: Houtou Jianweiling tablet (0.38 g), 4 tablets taken orally at a time, 3 times a day and Omeprazole Enteric-coated placebo tablet, taken 1 tablet orally once a day before breakfast.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omeprazole Tablet
Description: Omeprazole Enteric-coated tablet (20 mg), 1 tablet taken orally once a day before breakfast and Houtou Jianweiling placebo tablets, taken orally, 4 tablets at a time, 3 times a day.
Study: NCT05953870

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: slower tempo music that can quiet mind and make patients feel soothed
Study: NCT05830942

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking Exercise
Description: aerobic walking exercise using complex (cognitively engaging) walking tasks

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Walking Exercise
Description: aerobic walking exercise using complex (cognitively engaging) walking tasks

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prefrontal Active tDCS
Description: 20 minutes of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Prefrontal Sham tDCS
Description: 30 seconds of 2 milliamp transcranial direct current stimulation (tDCS) of prefrontal regions, delivered at each session
Study: NCT05815030

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.

Intervention type: OTHER
Group type: OTHER
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.

Intervention type: OTHER
Group type: OTHER
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.

Intervention type: OTHER
Group type: OTHER
Intervention: video informational/educational intervention
Description: Videos relating to PrEP use, its benefits, side effects, and other information. The educational/round-table video will highlight individuals from diverse backgrounds and identities who will share their experiences using PrEP, including perceived benefits and effectiveness, experienced barriers to PrEP uptake, their reasons for using PrEP, and their own self-efficacy. The control group's (generic / standard video) materials will be focused on PrEP uptake without a kink identity perspective. The treatment group's materials, however, will include videos that feature kink-identified individuals who discuss PrEP uptake through a kink perspective.
Study: NCT06143371

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAN10
Description: Single dose intravenous or Multiple doses subcutaneously

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAN10
Description: Single dose intravenous or Multiple doses subcutaneously